Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Journal of Molecular Signaling

Open Access

Scaffolding proteins in G-protein signaling

Journal of Molecular Signaling20072:13

https://doi.org/10.1186/1750-2187-2-13

Received: 30 August 2007

Accepted: 30 October 2007

Published: 30 October 2007

Abstract

Heterotrimeric G proteins are ubiquitous signaling partners of seven transmembrane-domain G-protein-coupled receptors (GPCRs), the largest (and most important pharmacologically) receptor family in mammals. A number of scaffolding proteins have been identified that regulate various facets of GPCR signaling. In this review, we summarize current knowledge concerning those scaffolding proteins that are known to directly bind heterotrimeric G proteins, and discuss the composition of the protein complexes they assemble and their effects on signal transduction. Emerging evidence about possible ways of regulation of activity of these scaffolding proteins is also discussed.

Background

The concept of scaffolding (or scaffold) proteins, formulated more than a decade ago (see [1] for an early review), is now widely accepted in different areas of cellular signaling. Scaffolding proteins simultaneously associate with two or more partners, thus providing specificity of signaling and enhancing the interactions between components of a particular signaling module [2, 3]. It should be mentioned that scaffolding proteins may not necessarily only function as "passive" anchoring platforms for "active" components of the signaling complex. Some scaffolding proteins may directly affect the activity of proteins they bind.

Heterotrimeric G proteins (recent reviews: [4, 5]) are ubiquitous signaling partners of seven transmembrane-domain G-protein-coupled receptors (GPCRs), the largest (and most important pharmacologically) receptor family in mammals. In addition to their role in signal transduction from canonical GPCRs, heterotrimeric G proteins are also involved in signaling downstream of a number of "non-canonical" receptors [6] and signaling events that do not employ transmembrane receptors at all [7]. While the number of G protein-coupled receptors in mammalian cells exceeds 1000, the number of heterotrimeric G proteins is much smaller, even taking into account the number of possible combinations of α, β and γ subunits. In the recent years, it has become clear that scaffolding proteins may provide not only signaling efficiency, but also specificity to G protein-coupled signaling.

This review aims to address the variety of scaffolding proteins that interact with heterotrimeric G proteins and the diversity of the signaling complexes they assemble. Proteins that belong to the classes of regulators (RGS) and activators (AGS) of heterotrimeric G-protein signaling, many of which can also act as scaffolds, have been recently covered in other reviews, and the reader is referred to the respective recent publications (RGS proteins: [8, 9]; AGS proteins: [10, 11]).

AKAPs

A-Kinase Anchoring Proteins (AKAPs) are a family of scaffolding proteins that target PKA and other signaling enzymes to specified subcellular locations [12, 13]. Each AKAP contains a conserved amphipathic helix responsible for high affinity binding to the dimer of the regulatory (R) subunits of PKA [14, 15], and a targeting domain that directs the PKA-AKAP complex to specific subcellular compartments [1620]. Due to their ability to interact with several signaling proteins, AKAPs bring PKA in a close proximity with a variety of signaling partners [2125]. Several AKAPs play a role in various aspects of G protein-coupled receptor signaling [26], and at least two of them directly interact with heterotrimeric G proteins.

AKAP-Lbc was identified as a PKA-anchoring protein highly expressed in the heart that also has a Rho-specific guanine nucleotide exchange (GEF) activity ([27, 28] reviewed by [29]). It was shown to interact with Rho in the inactive GDP-bound or nucleotide free form, but not with activated GTP-bound Rho. AKAP-Lbc was found to mediate activation of Rho by mutationally activated Gα12 and, to a lesser extent, by Gα13, but not several other tested Gα [28]. Moreover, AKAP-Lbc was shown to interact with Gα12 and to mediate Gα12-dependent Rho activation by lysophosphatidic acid (LPA) receptor ([28]; Fig. 1A) and by α1 adrenergic receptor, in the latter case mediating cardiomyocyte hypertrophy [30]. Anchored PKA phosphorylates AKAP-Lbc, thus allowing binding of 14-3-3, which in turn inhibits its RhoGEF activity by interfering with the interaction between AKAP-Lbc and RhoA [31, 32]. Inhibition of RhoGEF activity by 14-3-3 requires AKAP-Lbc oligomerization [33]. These findings imply that cellular cAMP levels would regulate sensitivity of Gα12-dependent signaling via AKAP-Lbc. AKAP-Lbc may also anchor PKCα, which might phosphorylate Rho or Rho GDP dissociation inhibitor (RhoGDI) although its precise role in the AKAP-Lbc complex is unknown [24].
Figure 1

Schematic representation of Gα12/Gα13-containing signaling complexes assembled by A-kinase anchoring proteins (AKAPs): AKAP-Lbc (A) and AKAP-110 (B). See main text for details and references.

AKAP-Lbc also assembles an activation complex for the lipid-dependent enzyme protein kinase D (PKD) [24]. It contributes to PKD activation in two ways: it recruits the upstream kinase PKCη and coordinates PKA phosphorylation events that release activated protein kinase D. Thus, AKAP-Lbc synchronizes PKA and PKC activities in a manner that leads to the activation of a third kinase, PKD [24].

Notably, in both cases (Gα12-Rho and PKA/PKC-PKD signaling) AKAP-Lbc receives signals from G protein-coupled receptors. It is not yet clear whether the same AKAP-Lbc complex may involve simultaneously Gα12/Rho and PKC/PKD and process these signals in parallel, or AKAP-Lbc/Gα12/Rho and AKAP-Lbc/PKC/PKD represent separate and independent signaling complexes.

AKAP110, expressed mainly in testis, was found to selectively interact with activated Gα13, but not Gα12 or other Gα [34]. Unlike AKAP-Lbc, AKAP110 does not affect GDP-GTP exchange by Rho (J. Niu and T. Voyno-Yasenetskaya, unpublished data). It also has no effect on GDP-GTP exchange and GTPase activity of Gα13 [34]. Gα13 binding to AKAP110 does not affect binding of the regulatory subunit of PKA, but leads to a release of the catalytic subunit (Fig. 1B). Thus, AKAP-110 appears to be a Gα13 effector that provides a cAMP-independent mechanism of PKA activation.

Interestingly, the PKA-binding site of AKAP110 is also able to bind ropporin [35]. Ropporin is known to bind rhophilin, which is a Rho binding protein and presumable Rho effector [36]. Thus, although activation of PKA by Gα13 via AKAP110 is Rho-independent, it cannot be excluded that AKAP110 may provide yet undefined additional link between Gα13 and Rho signaling.

AKAP120. Yet another PKA-anchoring protein, AKAP120, has been suggested to specifically interact with Gα13 but not several other Gα [37]. However the initial finding using the yeast two hybrid system has not been confirmed by other techniques, and no further studies of the Gα13-AKAP120 interaction have been reported. AKAP120 described in Ref. [37] is actually a fragment of one of the several alternatively spliced isoforms derived from the same gene, which include AKAPs 350, 450 and Yotiao. These proteins are located at centrosomes and/or Golgi apparatus and affect microtubule dynamics (AKAP350/450), or regulate cardiac potassium channel (Yotiao) [38, 39]. It would be important to establish whether any of these isoforms are able to interact with Gα13.

Tetratricopeptide repeat (TPR)-containing scaffolding proteins

TPR1 was initially identified as a protein containing three TPR motifs, which interacts with the GAP domain of neurofibromin (NF1) [40]. It also interacts with and is a co-chaperone of Hsp70 [41, 42]. TPR1 was found to interact with Gα16, as well as Gαq, Gαs, and to a much lesser extent with Gαi (but not Gα13 or Gαt), as well as with HA-Ras (but not Rho, Cdc42 and Rac) [43]. In the absence of Gα16, HA-Ras was found to bind to TPR1 preferentially in the activated conformation, however in the presence of Gα16 binding was similar for activated and inactive HA-Ras. Binding of Gα16 facilitated binding of HA-Ras to TPR1 and led to accumulation of the activated Ras (Fig. 2A), apparently by stabilizing the activated conformation, rather than by promoting GDP-GTP exchange. In contrast, binding of HA-Ras had no effect on the binding of Gα16. The physiological role of the formation of the Gα16-TPR1-Ras complex remains to be explored.
Figure 2

Signaling complexes assembled by TPR-repeat scaffolding proteins: TPR1 (A) and RACK1 (B). See main text for description.

Mammalian AGS3 and LGN proteins and their Drosophila homologue Pins, which contain N-terminal TPR domains and C-terminal domains with GoLoco motifs, act as scaffolds for Gαi and microtubule binding protein NuMA [44, 45]. This signaling complex plays a role in regulation of cell polarity and has been considered in detail elsewhere [7, 10, 11].

Another TPR protein, protein Ser/Thr phosphatase PP5, is able to interact with Gα12 and Gα13 [46]. It remains to be seen whether the ternary complexes exist that include PP5, Gα12/13 and other proteins, or binding of Gα12/13 and other proteins to the TPR domain of PP5 is mutually exclusive, i.e. whether PP5 can be considered as a bona fide scaffolding protein.

WD40 repeat proteins

Gβ belongs to the family of WD40 repeat proteins [47]. Gβγ acts as a scaffold itself by facilitating interaction between activated GPCRs and Gα, and also by recruiting GRK2 (β-ARK) to those GPCR that are phosphorylated by this kinase [48]. It also initiates signal transduction by recruiting other scaffolding or adaptor proteins. In yeast, as discussed below, it recruits a scaffolding protein Ste5p from the cytosol to the cell membrane, where it assembles a signaling complex containing the components of the MAPK cascade.

In mammalian cells, Gβ has been found to interact with other WD40 repeat proteins, namely RACK1 (Receptor for Activated C Kinase 1), dynein intermediate chain and an uncharacterized protein AAH20044 [4951]. Of these three proteins, only Gβγ-RACK1 interaction has been characterized in detail to date. RACK1 shares 57% amino acid similarity with Gβ1 Unlike Gβ, RACK1 does not have an N-terminal extension for binding Gγ. Although RACK1 does bind Gβγ, it does not interact with the Gα βγ heterotrimer (except that of transducin) or with Gα.

Binding of RACK1 to Gβγ affects some but not all Gβγ-mediated functions: while activation of phospholipase C β2 and adenylyl cyclase II are inhibited, Gβγ-mediated chemotaxis and activation of MAP kinase cascade are not affected. RACK1 does not affect signal transduction through the Gα subunits of Gi, Gs or Gq.

The association with Gβγ induces translocation of RACK1 from the cytosol to the plasma membrane. This has been suggested to be a mechanism to recruit PKC and other RACK1-binding proteins to the membrane [49, 50]. In particular, Gβγ-RACK1 mediated PKC recruitment to GPCRs could promote their efficient deactivation by this kinase, in a manner similar to the recruitment of GRK2 by Gβγ (see above). In addition, a number of Gβγ effectors, such as Ca2+ channels, phospholipase C β2 and adenylyl cyclase, as well as several Gα and RGS proteins can be regulated by PKC. Whether regulation of these proteins is subject to fine tuning by the Gβγ-RACK1 interaction has yet to be explored experimentally.

Another possibility is that the Gβγ-RACK1 complex might build larger signaling complexes, employing scaffolding properties of both Gβγ and RACK1. In this respect, it is of particular interest that some proteins bind to/are regulated by both Gβγ and RACK1. These include dynamin-1, involved in GPCR internalization; Src, a tyrosine kinase involved in Gβγ-mediated MAPK activation, and β-integrin ([52] and references therein).

Importantly, RACK1 is able to homodimerize [53], a property that may further expand its ability to form signaling complexes as schematically depicted in Fig. 2B. A model suggested by the latter study implicates a RACK1-based signaling complex in regulation of NMDA receptor (which is an ion channel) by a GPCR PAC1. According to the model of [53], in the inactive state one molecule of RACK1 in the dimer would bind NMDA receptor and link it to PAC1 via Gα βγ trimer, while the other PACK1 molecule would bind to a kinase Fyn, keeping it in a proximity to NMDA receptor but nevertheless preventing it from phosphorylating NMDAR (Fig. 2B). Upon PAC1 activation, the signaling complex is postulated to dissociate and released Fyn to phosphorylate and thus activate NMDA receptor [53]. It should be noted however that this model requires the ability of RACK1 to associate with G protein heterotrimer, which in most cases is not supported by experimental evidence (see above).

Kelch repeat proteins, although unrelated in their primary structure to WD40 repeats, form similar β-propeller structures that also mediate protein-protein interactions [54]. Two "Gβ-mimic" proteins, Gpb1 and Gpb2, containing kelch repeats rather than WD40 repeats, have been found to interact with a Gα subunit Gpa2 in yeast [55, 56]. Notably, there are no known canonical Gβγ interacting with Gpa2. Unlike canonical Gβγ, Gpb1 and Gpb2 do not facilitate, but on the contrary inhibit coupling of Gpa2 with its cognate GPCR. Whether interaction of Gα with Kelch repeat proteins is unique for yeast or similar interactions may exist in mammals remains to be explored.

Other scaffolding proteins

Radixin is a member of the ezrin-radixin-moesin (ERM) protein family that anchor actin filaments to the cell cortex and membrane proteins, and function in Rho signaling. ERM proteins are involved in such cytoskeleton-dependent processes as cell morphogenesis, migration and growth (reviewed [57, 58]). Not surprisingly, ERM proteins may be involved in tumor metastasis [59, 60]. ERM proteins are negatively regulated by an intramolecular interaction between the N- and C-terminal domains, and their ability to bind actin and other proteins is stimulated when this interaction is disrupted and the binding sites on radixin are unmasked [57].

Radixin was found to interact with activated (but not GDP-bound) Gα13 via its N-terminal domain [61]. This interaction apparently disrupted the interaction between the N- and C-terminal domains, leading to radixin "conformational activation" and increased binding to F-actin [61]. Dominant-negative deletion mutants of radixin could block transformation induced by mutationally activated Gα13, suggesting that radixin could act downstream of Gα13 in this process [61]. A suggestion that radixin may mediate cellular effects of Gα13 was further substantiated by a more recent study from our laboratory, which found that the C-terminal domain of radixin activates Rac1 and CAMKII, leading to stimulation of SRE (serum response element)-dependent gene transcription ([62]; Fig. 3).
Figure 3

Signaling from the Gα13-radixin complex.

EBP50 (ezrin-radixin-moesin-binding phosphoprotein 50, also termed NHERF1 for Na+-H+ exchanger regulatory factor 1) is a PDZ domain-containing scaffolding protein known to bind to a variety of proteins, including ERM proteins, channels, receptors, cytoskeletal elements, and cytoplasmic proteins (for a recent review, see [63]). EBP50 was found to interact with Gαq via its PDZ domains [64]. The interaction was more efficient with activated than with inactive form of Gαq; accordingly, stimulation of the thromboxane A2receptor (which is coupled to Gq) enhanced the Gαq-EBP50 interaction. EBP50 was also able to interact with Gαs, and stimulation of the β2-adrenergic receptor (coupled to Gαs) was found to promote EBP50 binding to Gαs. However, several other Gα tested (Gαi/o/t/z , Gα12/13, and Gα16) did not interact with EBP50. Sequestering of Gαq by EBP50 was found to interfere with the Gα-receptor interaction and to inhibit Gαq-dependent stimulation of PLCβ ([64]; Fig. 4). EBP50 is known to bind directly and to mediate recycling of a number of receptors [65, 66]; it was also found to inhibit internalization of the thromboxane A2β receptor induced by Gαq [67]. One of the future challenges would be to establish whether, in addition to blocking Gα interactions with receptors and effectors, Gα-EBP50 interaction may functionally link Gαq and/or Gαs to other interacting partners of EBP50.
Figure 4

The role of EBP50 (NERF) in downregulation of G protein signaling.

EBP50 has been found to directly interact with RACK1, another scaffolding protein capable of binding Gβγ (see above) [68]. This interaction was found to be involved in PKC-dependent regulation of an epithelial chloride channel cystic fibrosis transmembrane regulator (CFTR) [68]. Whether the ability of EBP50 and RACK1 to interact with each other is relevant to their ability to bind subunits of heterotrimeric G proteins is not known.

Scaffolding subunit of the protein phosphatase 2A (A subunit, PR65) was found to interact with Gα12 (but not related Gα13), which stimulated the activity of the catalytic PP2A subunit bound to the complex independently of the activation state of Gα12 [69, 70]. Intriguingly, the same scaffolding protein PR65 was found to interact with protein phosphatase 5 (PP5) [71], and PP5 was shown to interact with and to be activated by Gα12 and Gα13 [46]. It would be interesting to establish whether PR65 may play a role in assembling the Gα12/13-PP5 complex as well.

Scaffolding proteins that link heterotrimeric G proteins with MAP kinase cascades. The first such scaffolding protein, Ste5, was discovered in yeast (reviewed by [72, 73]). Ste5 is able to bind all three kinases (MAPKKK, MAPKK and MAPK) of the mating pathway, which promotes their mutual interactions and thereby facilitates signal transmission. Ste5 also binds to Gβγ. The latter property allows the recruitment of the Ste5/MAPK signaling complex to the stimulus-sensing receptor/G protein module, enabling signal transduction from GPCR via Gβγ to the MAPK cascade (Fig. 5A). Analogs of Ste5 act as scaffolds for other MAP kinase cascades in both yeast and mammalian cells [74, 75], and some of them are also able to interact with subunits of heterotrimeric G proteins.
Figure 5

Scaffolding proteins that link subunits of heterotrimeric G proteins with MAP kinase cascade. A, The role of Ste5 in the mating signaling in yeast. B, Signaling complex assembled by KSR1, leading to ERK activation. C, Signaling complex assembled by JLP, leading to activation of JNK (or p38, see discussion in the main text). LPA, lysophosphatidic acid; RA, retinoic acid.

Mammalian KSR1 protein (which shares no sequence similarity with Ste5) assembles the kinases of the ERK pathway (Raf-1, MEK1/2, ERK1/2) (reviewed by [74, 76]). KSR1 plays a role in ERK activation during inflammatory and stress responses and has been implicated in the onset of arthritis [77]. KSR1-facilitated ERK activation was also found to be essential for long-term memory formation and synaptic plasticity [78].

KSR-1 association with MEK kinases is constitutive, while binding to Raf and recruitment of ERK to the complex are Ras activation-dependent. Another protein constitutively bound to KSR1 and required for maximal stimulation the ERK cascade is casein kinase 2 [79]. KSR1 is able to interact with Gβγ via the γ subunit and is recruited to the plasma membrane upon LPA stimulation ([80]; Fig. 5B).

JNK-interacting leucine zipper protein (JLP) is a scaffolding protein (recently reviewed in [72]) involved in linking JNK with its substrate transcription factors (Myc and Max) and its upstream kinases (MKK4 and MEKK3) [81]. JLP interacts with kinesin light chain 1, which is required for its interaction with JNK and affects localization of the complex [82]. JLP has recently been found to interact specifically with Gα12 and Gα13, but not Gαs, Gαi or Gαq [83]. Although JLP binds both activated and inactive Gα13, the interaction is more pronounced with the activated form. Accordingly, JLP-Gα13 interaction is enhanced by lysophosphatidic acid (LPA) stimulation, which is known to activate Gα13. LPA-induced JNK activation in living cells is potentiated by overexpression of JLP. Thus, JLP appears to function in linking GPCR signaling to JNK activation by assembling a protein complex that involves Gα12 or Gα13 and the components of JNK signaling module ([83]; Fig. 5C). We have recently found that JLP can also assemble a complex containing Gα13 and apoptosis signal-regulating kinase 1 (ASK1), which is known to stimulate JNK and/or p38 in response to stress stimuli [84]. Although the functionality of this complex in terms of activation of downstream MAP kinases remains to be tested, this suggests that JLP may link Gα12/13 signaling with JNK through more than one kinase cascade. A physiological role for the Gα13-JLP-JNK signaling complex in retinoic acid-induced differentiation has recently been suggested [85].

Two JLP-related alternative splicing products are known (JIP4 and SPAG9), which differ from JLP in their N-termini and appear to have different selectivity towards JNK vs. p38 [86, 87]. Since Gα12/13-binding region in JLP is at the C-terminus and the C-terminal parts are conserved in all three isoforms, JIP4 and SPAG9 would also likely be able to interact with Gα12/13. Experimental confirmation of this interaction and its functional implications have not yet been reported.

Conclusion and perspectives

A number of scaffolding proteins for heterotrimeric G proteins have been identified in the recent years, and undoubtedly many more are still to be found. The knowledge of the composition of possible complexes formed by these scaffolds is essential for identification of the precise signaling pathways they may be involved in. This has been already achieved to some extent for a number of signaling complexes that involve heterotrimeric G proteins. Another layer of complexity is added by the events that determine when and at what levels these scaffolds are expressed in the cell and what are the fine tuning mechanisms that regulate their interactions with particular partners. In this respect, recent studies have highlighted some possible fine tuning mechanisms. First, the expression of scaffolding proteins may be regulated by relevant physiological stimuli, as evidenced by the work of Kashef et al. [85], who found that retinoic acid may induce expression of JLP, a scaffolding protein that assembles a complex transducing the signal from this ligand. Another example of regulation of a G protein-binding scaffold by a physiological stimulus, in this case growth factor stimulation [76], is Ras-dependent degradation of a protein IMP that controls KSR1 localization [88]. Another level of fine tuning may be achieved by posttranslational modifications of the proteins involved, and some cases of such regulation are beginning to emerge. It was suggested that binding of Gβγ may Ste5 may induce conformational changes in the latter, which make activation of MAP kinases bound to Ste5 more efficient [89]. Regulation of several G protein-binding scaffolding proteins by phosphorylation has been reported, including Ste5 and KSR1 [76, 89]. Sumoylation of the proteins of RGS-Rz subfamily was found to switch their function from stimulation of GTPase activity of Gα subunits to that of a scaffolding protein [90]. Clearly, detailed knowledge of not only composition of the complexes assembled by G protein-interacting scaffolding proteins, but although intricate regulation of the properties of all components of these complexes will be necessary for full understanding of their biological functions.

Declarations

Acknowledgements

This work was supported by grants from the National Institutes of Health GM56159 and HL06078 and by a grant from the American Heart Association (to TVY). TVY is an Established Investigator of the American Heart Association.

Authors’ Affiliations

(1)
Department of Pharmacology, College of Medicine, University of Illinois at Chicago

References

  1. Faux MC, Scott JD: Molecular glue: kinase anchoring and scaffold proteins. Cell 1996, 85:9–12.View ArticlePubMedGoogle Scholar
  2. Burack WR, Shaw AS: Signal transduction: hanging on a scaffold. Curr Opin Cell Biol 2000,12(2):211–216.View ArticlePubMedGoogle Scholar
  3. Hall RA, Lefkowitz RJ: Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res 2002,91(8):672–680.View ArticlePubMedGoogle Scholar
  4. McCudden CR, Hains MD, Kimple RJ, Siderovski DP, Willard FS: G-protein signaling: back to the future. Cell Mol Life Sci 2005,62(5):551–577.View ArticlePubMedGoogle Scholar
  5. Oldham WM, Hamm HE: Structural basis of function in heterotrimeric G proteins. Q Rev Biophys 2006,39(2):117–166.View ArticlePubMedGoogle Scholar
  6. Patel TB: Single transmembrane spanning heterotrimeric G protein-coupled receptors and their signaling cascades. Pharmacol Rev 2004,56(3):371–385.View ArticlePubMedGoogle Scholar
  7. Hampoelz B, Knoblich JA: Heterotrimeric G proteins: new tricks for an old dog. Cell 2004,119(4):453–456.View ArticlePubMedGoogle Scholar
  8. Willars GB: Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin Cell Dev Biol 2006,17(3):363–376.View ArticlePubMedGoogle Scholar
  9. Xie GX, Palmer PP: How regulators of G protein signaling achieve selective regulation. J Mol Biol 2007,366(2):349–365.View ArticlePubMedGoogle Scholar
  10. Blumer JB, Smrcka AV, Lanier SM: Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Ther 2007,113(3):488–506.View ArticlePubMedGoogle Scholar
  11. Cismowski MJ: Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin Cell Dev Biol 2006,17(3):334–344.View ArticlePubMedGoogle Scholar
  12. Colledge M, Scott JD: AKAPs: from structure to function. Trends Cell Biol 1999,9(6):216–221.View ArticlePubMedGoogle Scholar
  13. Tasken K, Aandahl EM: Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 2004,84(1):137–167.View ArticlePubMedGoogle Scholar
  14. Carr DW, Stofkohahn RE, Fraser IDC, Bishop SM, Acott TS, Brennan RG, Scott JD: Interaction of the Regulatory Subunit (RII) of cAMP-Dependent Protein-Kinase with RII-Anchoring Proteins Occurs through an Amphipathic Helix Binding Motif. J Biol Chem 1991,266(22):14188–14192.PubMedGoogle Scholar
  15. Newlon MG, Roy M, Morikis D, Carr DW, Westphal R, Scott JD, Jennings PA: A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. Embo J 2001,20(7):1651–1662.View ArticlePubMedGoogle Scholar
  16. Alto N, Carlisle Michel JJ, Dodge KL, Langeberg LK, Scott JD: Intracellular targeting of protein kinases and phosphatases. Diabetes 2002, 51 Suppl 3:S385–8.View ArticlePubMedGoogle Scholar
  17. Dell'Acqua ML, Faux MC, Thorburn J, Thorburn A, Scott JD: Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4,5-bisphosphate. Embo J 1998,17(8):2246–2260.View ArticlePubMedGoogle Scholar
  18. Kapiloff MS, Schillace RV, Westphal AM, Scott JD: mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 1999,112(16):2725–2736.PubMedGoogle Scholar
  19. Westphal RS, Coffee RL Jr., Marotta A, Pelech SL, Wadzinski BE: Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 1999,274(2):687–692.View ArticlePubMedGoogle Scholar
  20. Westphal RS, Soderling SH, Alto NM, Langeberg LK, Scott JD: Scar/WAVE-1, a Wiskott-Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold. Embo J 2000,19(17):4589–4600.View ArticlePubMedGoogle Scholar
  21. Dodge KL, Khouangsathiene S, Kapiloff MS, Mouton R, Hill EV, Houslay MD, Langeberg LK, Scott JD: mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. Embo J 2001,20(8):1921–1930.View ArticlePubMedGoogle Scholar
  22. Schillace RV, Scott JD: Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. Curr Biol 1999,9(6):321–324.View ArticlePubMedGoogle Scholar
  23. Tasken KA, Collas P, Kemmners WA, Witczak O, Conti M, Tasken K: Phosphodiesterase 4D and protein kinase A type II constitute a signaling unit in the centrosomal area. J Biol Chem 2001,276(25):21999–22002.View ArticlePubMedGoogle Scholar
  24. Carnegie GK, Smith FD, McConnachie G, Langeberg LK, Scott JD: AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell 2004,15(6):889–899.View ArticlePubMedGoogle Scholar
  25. Wong W, Scott JD: AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004,5(12):959–970.View ArticlePubMedGoogle Scholar
  26. Appert-Collin A, Baisamy L, Diviani D: Regulation of G protein-coupled receptor signaling by A-kinase anchoring proteins. J Recept Signal Transduct Res 2006,26(5–6):631–646.View ArticlePubMedGoogle Scholar
  27. Klussmann E, Pepperle B, Edemir B, Bouchaala C, Maric K, Rosenthal W: The protein kinase A anchoring protein Ht31, the Rho GEF factor proto-Lbc and the breast cancer auxillary protein Brx are encoded by a single gene. N-S Arch Pharmacol 2001,363(4):R66-R66.Google Scholar
  28. Diviani D, Soderling J, Scott JD: AKAP-Lbc anchors protein kinase A and nucleates G alpha(12)-selective Rho-mediated stress fiber formation. J Biol Chem 2001,276(47):44247–44257.View ArticlePubMedGoogle Scholar
  29. Diviani D, Baisamy L, Appert-Collin A: AKAP-Lbc: A molecular scaffold for the integration of cyclic AMP and Rho transduction pathways. Eur J Cell Biol 2006.Google Scholar
  30. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D: The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 2007,104(24):10140–10145.View ArticlePubMedGoogle Scholar
  31. Diviani D, Abuin L, Cotecchia S, Pansier L: Anchoring of both PKA and 14–3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. Embo J 2004,23(14):2811–2820.View ArticlePubMedGoogle Scholar
  32. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD, Pawson T: Proteomic, functional, and domain-based analysis of in vivo 14–3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Current Biology 2004,14(16):1436–1450.View ArticlePubMedGoogle Scholar
  33. Baisamy L, Jurisch N, Diviani D: Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem 2005,280(15):15405–15412.View ArticlePubMedGoogle Scholar
  34. Niu JX, Vaiskunaite R, Suzuki N, Kozasa T, Carr DW, Dulin N, Voyno-Yasenetskaya TA: Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation. Current Biology 2001,11(21):1686–1690.View ArticlePubMedGoogle Scholar
  35. Carr DW, Fujita A, Stentz CL, Liberty GA, Olson GE, Narumiya S: Identification of sperm-specific proteins that interact with A-kinase anchoring proteins in a manner similar to the type II regulatory subunit of PKA. J Biol Chem 2001,276(20):17332–17338.View ArticlePubMedGoogle Scholar
  36. Fujita A, Nakamura K, Kato T, Watanabe N, Ishizaki T, Kimura K, Mizoguchi A, Narumiya S: Ropporin, a sperm-specific binding protein of rhophilin, that is localized in the fibrous sheath of sperm flagella. J Cell Sci 2000,113(1):103–112.PubMedGoogle Scholar
  37. Suzuki M, Furuuchi K, Tonoki H, Ozaki T, Iizuka K, Murakami T, Kitabatake A, Kawaguchi H: A novel A-kinase anchoring protein in the heart interacts with G alpha 13. Jpn Heart J 1999,40(2):199–208.View ArticlePubMedGoogle Scholar
  38. Chen L, Kass RS: Dual roles of the A kinase-anchoring protein Yotiao in the modulation of a cardiac potassium channel: a passive adaptor versus an active regulator. Eur J Cell Biol 2006,85(7):623–626.View ArticlePubMedGoogle Scholar
  39. Larocca MC, Jin M, Goldenring JR: AKAP350 modulates microtubule dynamics. Eur J Cell Biol 2006,85(7):611–619.View ArticlePubMedGoogle Scholar
  40. Murthy AE, Bernards A, Church D, Wasmuth J, Gusella JF: Identification and characterization of two novel tetratricopeptide repeat-containing genes. DNA Cell Biol 1996,15(9):727–735.View ArticlePubMedGoogle Scholar
  41. Wu SJ, Liu FH, Hu SM, Wang C: Different combinations of the heat-shock cognate protein 70 (hsc70) C-terminal functional groups are utilized to interact with distinct tetratricopeptide repeat-containing proteins. Biochem J 2001, 359:419–426.View ArticlePubMedGoogle Scholar
  42. Oh WK, Song J: Cooperative interaction of Hsp40 and TPR1 with Hsp70 reverses Hsp70-HspBp1 complex formation. Mol Cells 2003,16(1):84–91.PubMedGoogle Scholar
  43. Marty C, Browning DD, Ye RD: Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras. Mol Cell Biol 2003,23(11):3847–3858.View ArticlePubMedGoogle Scholar
  44. Du QS, Taylor L, Compton DA, Macara IG: LGN blocks the ability of NuMA to bind and stabilize microtubules: A mechanism for mitotic spindle assembly regulation. Current Biology 2002,12(22):1928–1933.View ArticlePubMedGoogle Scholar
  45. Du QS, Macara IG: Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. Cell 2004,119(4):503–516.View ArticlePubMedGoogle Scholar
  46. Yamaguchi Y, Katoh H, Mori K, Negishi M: G alpha(12) and G alpha(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. Current Biology 2002,12(15):1353–1358.View ArticlePubMedGoogle Scholar
  47. Wall MA, Coleman DE, Lee E, Iniguezlluhi JA, Posner BA, Gilman AG, Sprang SR: The Structure of the G-Protein Heterotrimer G(I-Alpha-1)Beta(1)Gamma(2). Cell 1995,83(6):1047–1058.View ArticlePubMedGoogle Scholar
  48. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ: Role of Beta-Gamma-Subunits of G-Proteins in Targeting the Beta-Adrenergic-Receptor Kinase to Membrane-Bound Receptors. Science 1992,257(5074):1264–1267.View ArticlePubMedGoogle Scholar
  49. Chen S, Dell EJ, Lin F, Sai J, Hamm HE: RACK1 regulates specific functions of Gbetagamma. J Biol Chem 2004,279(17):17861–17868.View ArticlePubMedGoogle Scholar
  50. Chen S, Spiegelberg BD, Lin F, Dell EJ, Hamm HE: Interaction of Gbetagamma with RACK1 and other WD40 repeat proteins. J Mol Cell Cardiol 2004,37(2):399–406.View ArticlePubMedGoogle Scholar
  51. Dell EJ, Connor J, Chen S, Stebbins EG, Skiba NP, Mochly-Rosen D, Hamm HE: The betagamma subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins. J Biol Chem 2002,277(51):49888–49895.View ArticlePubMedGoogle Scholar
  52. Chen S, Lin F, Hamm HE: RACK1 binds to a signal transfer region of G betagamma and inhibits phospholipase C beta2 activation. J Biol Chem 2005,280(39):33445–33452.View ArticlePubMedGoogle Scholar
  53. Thornton C, Tang KC, Phamluong K, Luong K, Vagts A, Nikanjam D, Yaka R, Ron D: Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization. J Biol Chem 2004,279(30):31357–31364.View ArticlePubMedGoogle Scholar
  54. Adams J, Kelso R, Cooley L: The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000,10(1):17–24.View ArticlePubMedGoogle Scholar
  55. Harashima T, Heitman J: The G alpha protein GPa2 controls yeast differentiation by interacting with Kelch repeat proteins that mimic G beta subunits. Molecular Cell 2002,10(1):163–173.View ArticlePubMedGoogle Scholar
  56. Harashima T, Heitman J: G alpha subunit Gpa2 recruits kelch repeat subunits that inhibit receptor-G protein coupling during cAMP-induced dimorphic transitions in Saccharomyces cerevisiae. Mol Biol Cell 2005,16(10):4557–4571.View ArticlePubMedGoogle Scholar
  57. Bretscher A, Edwards K, Fehon RG: ERM proteins and merlin: Integrators at the cell cortex. Nat Rev Mol Cell Bio 2002,3(8):586–599.View ArticleGoogle Scholar
  58. Polesello C, Payre F: Small is beautiful: what flies tell us about ERM protein function in development. Trends Cell Biol 2004,14(6):294–302.View ArticlePubMedGoogle Scholar
  59. Khanna C, Wan XL, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004,10(2):182–186.View ArticlePubMedGoogle Scholar
  60. Yu YL, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G: Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004,10(2):175–181.View ArticlePubMedGoogle Scholar
  61. Vaiskunaite R, Adarichev V, Furthmayr H, Kozasa T, Gudkov A, Voyno-Yasenetskaya TA: Conformational activation of radixin by G(13) protein alpha subunit. J Biol Chem 2000,275(34):26206–26212.View ArticlePubMedGoogle Scholar
  62. Liu GQ, Voyno-Yasenetskaya TA: Radixin stimulates Rac1 and Ca2+/calmodulin-dependent kinase, CaMKII - Cross-talk with G alpha(13) signaling. J Biol Chem 2005,280(47):39042–39049.View ArticlePubMedGoogle Scholar
  63. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY, Shenolikar S: The Association of NHERF Adaptor Proteins with G Protein-Coupled Receptors and Receptor Tyrosine Kinases. Annu Rev Physiol 2006, 68:491–505.View ArticlePubMedGoogle Scholar
  64. Rochdi MD, Watier V, La Madeleine C, Nakata H, Kozasa T, Parent JL: Regulation of GTP-binding protein alpha q (Galpha q) signaling by the ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50). J Biol Chem 2002,277(43):40751–40759.View ArticlePubMedGoogle Scholar
  65. Gage RM, Matveeva EA, Whiteheart SW, von Zastrow M: Type I PDZ ligands are sufficient to promote rapid recycling of G protein-coupled receptors independent of binding to N-ethylmaleimide-sensitive factor. J Biol Chem 2005,280(5):3305–3313.View ArticlePubMedGoogle Scholar
  66. Li JG, Chen CG, Liu-Chen LY: Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. J Biol Chem 2002,277(30):27545–27552.View ArticlePubMedGoogle Scholar
  67. Rochdi MD, Parent JL: G alpha(q)-coupled receptor internalization specifically induced by G alpha(q) signaling - Regulation by EBP50. J Biol Chem 2003,278(20):17827–17837.View ArticlePubMedGoogle Scholar
  68. Liedtke CM, Yun CH, Kyle N, Wang D: Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor. J Biol Chem 2002,277(25):22925–22933.View ArticlePubMedGoogle Scholar
  69. Zhu D, Kosik KS, Meigs TE, Yanamadala V, Denker BM: Galpha12 directly interacts with PP2A: evidence for Galpha12-stimulated PP2A phosphatase activity and dephosphorylation of microtubule-associated protein, tau. J Biol Chem 2004,279(53):54983–54986.View ArticlePubMedGoogle Scholar
  70. Zhu D, Tate RI, Ruediger R, Meigs TE, Denker BM: Domains necessary for Galpha12 binding and stimulation of protein phosphatase-2A (PP2A): Is Galpha12 a novel regulatory subunit of PP2A? Mol Pharmacol 2007,71(5):1268–1276.View ArticlePubMedGoogle Scholar
  71. Lubert EJ, Hong Y, Sarge KD: Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: evidence for a heterotrimeric form of protein phosphatase 5. J Biol Chem 2001,276(42):38582–38587.View ArticlePubMedGoogle Scholar
  72. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP: Scaffold proteins of MAP-kinase modules. Oncogene 2007,26(22):3185–3202.View ArticlePubMedGoogle Scholar
  73. Elion EA: The Ste5p scaffold. J Cell Sci 2001,114(22):3967–3978.PubMedGoogle Scholar
  74. Morrison DK, Davis RJ: Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Bi 2003, 19:91–118.View ArticleGoogle Scholar
  75. Whitmarsh AJ, Cavanagh L, Tournier C, Yasuda L, Davis RJ: Mammalian scaffold complex that selectively mediates MAP kinase activation. Science 1998,281(5383):1671–1674.View ArticlePubMedGoogle Scholar
  76. Claperon A, Therrien M: KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 2007,26(22):3143–3158.View ArticlePubMedGoogle Scholar
  77. Fusello AM, Mandik-Nayak L, Shih F, Lewis RE, Allen PM, Shaw AS: The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis. J Immunol 2006,177(9):6152–6158.PubMedGoogle Scholar
  78. Shalin SC, Hernandez CM, Dougherty MK, Morrison DK, Sweatt JD: Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation. Neuron 2006,50(5):765–779.View ArticlePubMedGoogle Scholar
  79. Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK: CK2 is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol 2007,17(2):179–184.View ArticlePubMedGoogle Scholar
  80. Bell B, Xing HM, Yan K, Gautam N, Muslin AJ: KSR-1 binds to G-protein beta gamma subunits and inhibits beta gamma-induced mitogen-activated protein kinase activation. J Biol Chem 1999,274(12):7982–7986.View ArticlePubMedGoogle Scholar
  81. Lee CM, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP: JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A 2002,99(22):14189–14194.View ArticlePubMedGoogle Scholar
  82. Nguyen Q, Lee CM, Le A, Reddy EP: JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. J Biol Chem 2005,280(34):30185–30191.View ArticlePubMedGoogle Scholar
  83. Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN: JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry 2005,44(43):14090–14096.View ArticlePubMedGoogle Scholar
  84. Kutuzov MA, Andreeva AV, Voyno-Yasenetskaya TA: Regulation of apoptosis signal-regulating kinase 1 degradation by G{alpha}13. Faseb J 2007, 21:3727–36.View ArticlePubMedGoogle Scholar
  85. Kashef K, Xu H, Reddy EP, Dhanasekaran DN: Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem 2006,98(4):715–722.View ArticlePubMedGoogle Scholar
  86. Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, Herr JC, Okumura K, Hasegawa A, Koyama K, Suri A: Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J 2005,389(Pt 1):73–82.PubMedGoogle Scholar
  87. Kelkar N, Standen CL, Davis RJ: Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol 2005,25(7):2733–2743.View ArticlePubMedGoogle Scholar
  88. Matheny SA, Chen C, Kortum RL, Razidlo GL, Lewis RE, White MA: Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 2004,427(6971):256–260.View ArticlePubMedGoogle Scholar
  89. Dard N, Peter M: Scaffold proteins in MAP kinase signaling: more than simple passive activating platforms. Bioessays 2006,28(2):146–156.View ArticlePubMedGoogle Scholar
  90. Rodriguez-Munoz M, Bermudez D, Sanchez-Blazquez P, Garzon J: Sumoylated RGS-Rz proteins act as scaffolds for Mu-opioid receptors and G-protein complexes in mouse brain. Neuropsychopharmacology 2007,32(4):842–850.View ArticlePubMedGoogle Scholar

Copyright

© Andreeva et al. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement